H-1B sponsorship profile: Syros Pharmaceuticals, Inc. Across U.S. Department of Labor LCA disclosures, Syros Pharmaceuticals, Inc filed 5 Labor Condition Applications covering 5 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 80% (4 certified of 5 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Syros Pharmaceuticals, Inc’s H-1B petitions range from $167,403 at the low end to $432,647 at the high end, with a petition-weighted average of $280,020. That range reflects the mix of occupations the company sponsors, led by Senior Manager, Financial Planning & Analysis (2 petitions at $167,403 avg), followed by SVP Global Regulatory Affairs & Quality & Op Excellence and Associate Director of Drug Safety. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Syros Pharmaceuticals, Inc is headquartered in Cambridge, MA under NAICS code 54171, and places H-1B workers across 1 state, most heavily in MA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Syros Pharmaceuticals, Inc ranks. By H-1B petition volume, Syros Pharmaceuticals, Inc is #26,547 of 119,880 employers nationally and #1,208 of 5,193 employers headquartered in MA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.